American Renal Associates (ARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5 | -5,145 | 22,467 | 11,293 | -1,219 |
| Depreciation Amortization | 21,570 | 10,552 | 41,783 | 30,844 | 20,426 |
| Income taxes - deferred | -138 | 214 | 2,350 | -5,884 | -5,737 |
| Accounts receivable | -8,021 | 206 | 13,118 | 13,965 | 7,753 |
| Accounts payable and accrued liabilities | -1,434 | -12,667 | 25,661 | 20,602 | 19,428 |
| Other Working Capital | -12,968 | -14,770 | 36,557 | 40,180 | 42,649 |
| Other Operating Activity | 8,744 | 11,617 | -35,532 | -27,129 | -24,821 |
| Operating Cash Flow | $7,748 | $-9,993 | $106,404 | $83,871 | $58,479 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,869 | -5,200 | -42,458 | -26,572 | -15,918 |
| Net Acquisitions | -6,590 | -6,590 | -388 | N/A | N/A |
| Investing Cash Flow | $-17,459 | $-11,790 | $-42,846 | $-26,572 | $-15,918 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 73,551 | 46,857 | 82,389 | 52,576 | 28,946 |
| Debt Repayment | -23,069 | -12,661 | -90,428 | -59,903 | -33,198 |
| Common Stock Issued | 67 | 70 | 1,398 | 1,157 | 396 |
| Common Stock Repurchased | -338 | -338 | -838 | -421 | -367 |
| Dividend Paid | -25 | -11 | -332 | -320 | -278 |
| Other Financing Activity | -25,689 | -2,563 | -72,058 | -60,037 | -40,178 |
| Financing Cash Flow | $24,497 | $31,354 | $-79,869 | $-66,948 | $-44,679 |
| Beginning Cash Position | 55,300 | 55,300 | 71,611 | 71,611 | 71,611 |
| End Cash Position | 70,086 | 64,871 | 55,300 | 61,962 | 69,493 |
| Net Cash Flow | $14,786 | $9,571 | $-16,311 | $-9,649 | $-2,118 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,748 | -9,993 | 106,404 | 83,871 | 58,479 |
| Capital Expenditure | -14,169 | -8,500 | -44,960 | -29,074 | -18,418 |
| Free Cash Flow | -6,421 | -18,493 | 61,444 | 54,797 | 40,061 |